Avidity Partners Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,063,000
| Closed | -$2.29M | – | 84 |
|
|
2024
Q3 | $2.29M | Sell |
1,063,000
-610,538
| -36% | -$1.31M | 0.12% | 74 |
|
|
2024
Q2 | $8.64M | Hold |
1,673,538
| – | – | 0.37% | 65 |
|
|
2024
Q1 | $8.95M | Hold |
1,673,538
| – | – | 0.29% | 71 |
|
|
2023
Q4 | $13M | Buy |
1,673,538
+92,396
| +6% | +$720K | 0.48% | 54 |
|
|
2023
Q3 | $6.25M | Buy |
1,581,142
+117,108
| +8% | +$463K | 0.25% | 72 |
|
|
2023
Q2 | $4.61M | Buy |
1,464,034
+559,404
| +62% | +$1.76M | 0.16% | 83 |
|
|
2023
Q1 | $2.42M | Buy |
904,630
+4,630
| +0.5% | +$12.4K | 0.08% | 77 |
|
|
2022
Q4 | $3.23M | Hold |
900,000
| – | – | 0.07% | 71 |
|
|
2022
Q3 | $5.8M | Buy |
+900,000
| New | +$5.8M | 0.12% | 73 |
|